Article Text


Matrix metalloproteinase 3 is regulated by the laminin LAMA4 in human osteoarthritis
  1. F C Fuerst1,
  2. S M Kielhauser1,
  3. G Gruber1,
  4. M H Stradner1,
  5. H Angerer1,
  6. M L Kremser1,
  7. D Setzagel1,
  8. W B Graninger1
  1. 1Department of Rheumatology and Immunology, Medical University Graz, Graz, Austria


Background Osteoarthritis (OA) is characterised by a loss of cartilage extracellular matrix and chondrocyte hypertrophy. Syndecan 4 was shown to regulate ADAMTS5 and matrix metalloproteinase 3 (MMP3) which is crucial for cartilage breakdown. Syndecans have a binding site for laminins like LAMA4. Therefore the authors examined the expression and function of LAMA4 in OA cartilage.

Methods The authors collected osteoarthritic cartilage specimen (n=20) from patients undergoing total knee replacement and performed immunohistochemistry for Syndecan 4 and LAMA4. Furthermore human chondrocytes cultures were treated with the LAMA4 blocking antibody 2A3 and gene expression of MMP3, MMP13, ADAMTS5, LAMA4 and Syndecan 4 was measured using RT-PCR.

Results LAMA4 and Syndecan 4 are specifically co-expressed in hypertrophic chondrocyte clusters. Compared to sections from low-grade OA LAMA4 staining is significantly stronger in high-grade OA. Blocking LAMA4 in vitro leads to a significant (p<0.03) suppression of MMP3 expression.

Conclusion LAMA4 is expressed selectively in high-grade OA and regulates expression of MMP3 presumably via syndecan 4.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.